[Salbutamol as a beta-adrenergic stimulator in bronchospastic pulmonary conditions].
D000318:Adrenergic beta-Agonists / Q000627:therapeutic use; D000328:Adult; D000336:Aerosols; D000368:Aged; D001249:Asthma / Q000188:drug therapy*; D001991:Bronchitis / Q000188:drug therapy; D001993:Bronchodilator Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D006321:Heart / Q000187:drug effects; D006801:Humans; D008297:Male; D009921:Metaproterenol / Q000627:therapeutic use; D008875:Middle Aged; D009928:Organ Specificity; D010627:Phenethylamines / Q000627:therapeutic use*; D012118:Resorcinols / Q000627:therapeutic use*; D012138:Respiratory Therapy; D013147:Spirometry
D000318:Adrenergic beta-Agonists; D000336:Aerosols; D001993:Bronchodilator Agents; D010627:Phenethylamines; D012118:Resorcinols; D009921:Metaproterenol
Salbutamol som beta-adrenerg stimulator ved bronkospastiske lungelidelser.